Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer

OBJECTIVES: Optimal adjuvant treatment for early-stage clear cell and serous endometrial cancer remains unclear. We report outcomes for women with surgically staged International Federation of Gynecology and Obstetrics (FIGO) stage I clear cell, serous, and mixed endometrial cancers following adjuva...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeans, Elizabeth B, Breen, William G, Mullikin, Trey C, Looker, Brittany A, Mariani, Andrea, Keeney, Gary L, Haddock, Michael G, Petersen, Ivy A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223628/
https://www.ncbi.nlm.nih.gov/pubmed/33563642
http://dx.doi.org/10.1136/ijgc-2020-002217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223628/
https://www.ncbi.nlm.nih.gov/pubmed/33563642
http://dx.doi.org/10.1136/ijgc-2020-002217

Ejemplares similares